Ellevest Inc’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9
Closed 1663
2021
Q2
$0 Buy
+9
New +$177 ﹤0.01% 1469
2021
Q1
Sell
-18
Closed 1398
2020
Q4
$0 Buy
+18
New +$322 ﹤0.01% 1423

Ellevest Inc's TBIO Position: Q3 2021 in Review

Ellevest Inc sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 9 shares.

Ellevest Inc first reported a position in TBIO in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Ellevest Inc reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Ellevest Inc sold 9 Translate Bio, Inc. Common Stock shares in Q3 2021.
  • Ellevest Inc first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Ellevest Inc's Translate Bio, Inc. Common Stock position peaked at $0 in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.